Aurinia Pharmaceuticals Inc.
Support and Resistance Levels
Past performance
News About AUPH
All events for AUPH
All deals for AUPH
Financial Ratios
Financial Statements
AUPH vs Sector & Peers
About Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. The company's flagship product is LUPKYNIS, an approved treatment designed for adult individuals suffering from active lupus nephritis. Furthermore, Aurinia maintains a strategic collaboration and licensing agreement with Otsuka Pharmaceutical Co., Ltd. The firm's main corporate office is located in Victoria, Canada. Website auriniapharma.com
Headquarters Edmonton, AB, CA